In thyroid cancer cells, over expression of the IGF2BP3/IGF2 axis correlates with enhanced activation of the Akt and ERK pathways, increased cell proliferation and sensitivity to the dual inhibitor OSI-906 [82]. The gene discussed is AKT1; the disease is thyroid cancer.